LAZARD ASSET MANAGEMENT LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 214 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2023. The put-call ratio across all filers is 2.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2023$69
+21.1%
1,103
-15.9%
0.00%
Q4 2022$57
-100.0%
1,312
-88.4%
0.00%
-100.0%
Q3 2021$1,159,000
+1159.8%
11,277
+1268.6%
0.00%
Q4 2020$92,0008240.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 645,539$69,144,0007.84%
DAFNA Capital Management LLC 206,911$22,162,0005.57%
Eagle Health Investments LP 192,639$20,634,0005.03%
Casdin Capital, LLC 1,550,000$166,021,0004.68%
CADIAN CAPITAL MANAGEMENT, LP 450,657$48,270,0002.65%
Avidity Partners Management LP 995,000$106,574,0002.26%
Integral Health Asset Management, LLC 75,000$8,033,0002.22%
Rock Springs Capital Management LP 859,755$92,088,0002.13%
Boxer Capital, LLC 507,374$54,345,0002.11%
EFG Asset Management (North America) Corp. 112,715$12,082,0001.58%
View complete list of BLUEPRINT MEDICINES CORP shareholders